Franklin Resources Inc Biogen Inc. Transaction History

Franklin Resources Inc

$313 Billion
Q2 2024

A detailed history of Franklin Resources Inc transactions in Biogen Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 388,470 shares of BIIB stock, worth $67.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

388,470

Previous 385,583 0.75%

Holding current value

$67.5 Million

Previous $83.1 Million 8.31%

% of portfolio

0.03%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $550,031 - $683,410	2,887 Added 0.75%	388,470 $90.1 Million
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $23.9 Million - $30.2 Million	-112,766 Reduced 22.63%	385,583 $83.1 Million
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $29 Million - $34.9 Million	-130,185 Reduced 20.71%	498,349 $129 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $47 Million - $53.1 Million	185,742 Added 41.95%	628,534 $162 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $4.71 Million - $5.44 Million	17,106 Added 4.02%	442,792 $126 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $924,129 - $1.05 Million	3,602 Added 0.85%	425,686 $118 Million
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $3.24 Million - $3.94 Million	12,842 Added 3.14%	422,084 $117 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $702,246 - $968,335	-3,607 Reduced 0.87%	409,242 $109 Million
Q2 2022 Aug 11, 2022	SELL	$187.54 - $223.02 $475,038 - $564,909	-2,533 Reduced 0.61%	412,849 $84.2 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $8.93 Million - $11.3 Million	-46,100 Reduced 9.99%	415,382 $87.5 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $5.56 Million - $7.14 Million	-24,813 Reduced 5.1%	461,482 $111 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $4.24 Million - $5.53 Million	14,995 Added 3.18%	486,295 $138 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $15.3 Million - $24.5 Million	-58,979 Reduced 11.12%	471,300 $163 Million
Q1 2021 May 13, 2021	BUY	$242.95 - $284.63 $13.7 Million - $16.1 Million	56,427 Added 11.91%	530,279 $148 Million
Q4 2020 Feb 10, 2021	SELL	$236.26 - $355.63 $28.5 Million - $42.8 Million	-120,445 Reduced 20.27%	473,852 $116 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $4.51 Million - $5.2 Million	17,024 Added 2.95%	594,297 $169 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $17.8 Million - $23.6 Million	-68,799 Reduced 10.65%	577,273 $162 Million
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $15.3 Million - $19.4 Million	56,942 Added 9.67%	646,072 $204 Million
Q4 2019 Feb 12, 2020	BUY	$220.06 - $304.07 $3.64 Million - $5.03 Million	16,529 Added 2.89%	589,130 $175 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $116 Million - $130 Million	-533,621 Reduced 48.24%	572,601 $133 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $6.42 Million - $7.07 Million	29,269 Added 2.72%	1,106,222 $259 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $25.1 Million - $39.2 Million	-115,763 Reduced 9.71%	1,076,953 $255 Million
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $11.2 Million - $14.1 Million	40,090 Added 3.48%	1,192,716 $359 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $1.07 Million - $1.4 Million	3,642 Added 0.32%	1,152,626 $407 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $1.62 Million - $1.93 Million	6,288 Added 0.55%	1,148,984 $333 Million
Q1 2018 May 10, 2018	SELL	$260.13 - $367.91 $76.8 Million - $109 Million	-295,324 Reduced 20.54%	1,142,696 $313 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $14.1 Million - $15.8 Million	45,975 Added 3.3%	1,438,020 $458 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $391 Million - $459 Million	1,392,045	1,392,045 $436 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Biogen Inc. Transaction History